The SUPPRESS-AF randomised trial showed no significant overall reduction in 1-year atrial tachyarrhythmia recurrence with additional left atrial low-voltage-area (LVA) ablation versus pulmonary vein isolation (PVI) alone in persistent atrial fibrillation (AF) with LVAs, underscoring the need to understand outcome...
N. Tanaka, M. Okada, M. Masuda et al.· European Heart Journal· 0 citations
Cardiogenic shock (CS) is a heterogeneous condition with high mortality, and valvular heart disease (VHD) represents an important underlying cause. Although valvular intervention has been proposed for patients with CS and severe VHD, its prognostic benefit remains uncertain, and long-term outcome data are scarce....
S. Kawanami, Y. Egami, K. Nagai et al.· European Heart Journal· 0 citations
Atherectomy using rotational (RA) or orbital (OA) devices facilitates percutaneous coronary intervention (PCI) in severely calcified lesions. However, the optimal revascularization strategy following plaque modification remains uncertain.
We aimed to compare one-year clinical outcomes between stent and non...
H. Nohara, Y. Egami, T. Mukai et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.